New migraine guidelines focus on efficacy, prevention, and patient-centric approach

mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting

A large number of therapies are used prophylactically to prevent or abort migraine headaches but only 7 have proven efficacy, according to newly released guidelines.

The authors of the guidelines, issued jointly by the American Academy of Neurology (AAN) and the American Headache Society (AHS), acknowledged that other agents are likely to be effective but that the supportive data are weaker. They encouraged use of proven therapies as first-line strategies in migraine prevention.

The guidelines, which were published in the journal Neurology and presented at the 64th Annual Meeting of the AAN in New Orleans, Louisiana, United States, were based on a literature search of published studies in migraine treatment. Of the 7 therapies that met the strongest criterion of...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Neurology, Pharmacology, Primary Care and tagged , , , , , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.